Pharmaceutical Executive October 11, 2024
Ira Studin, PhD

A value deficit and potential consumer value proposition.

At some point, something new in a particular market becomes a development and, occasionally, if the development has sufficient traction, it can reshape a market. This discussion suggests Amazon’s presence in the pharma market could potentially fit that picture for the part of the market that falls below specialty products and orphan conditions.

Amazon’s healthcare business focuses on what might be called the transactional dimension of the healthcare system. It targets the time, scheduling, and financial burden patients experience. Its underlying assumption is that this burden is increasing and by leveraging its core competency in IT and operations, it can make a business by leaning into logistics to produce superior customer value.

...

Today's Sponsors

LEK
ZeOmega

Today's Sponsor

LEK

 
Topics: Pharma, Pharma / Biotech
Pharmacy deserts are appearing across U.S. as Rite Aid, Walgreens, CVS drug store closures spread
The Evolving Role and Importance of Pharmacists in the Health Care System
AI in Pharma Shows Promise With Faster Development, Lower Costs
Recent Trends in Medicaid Outpatient Prescription Drugs and Spending
Robust Evidence Synthesis To Support Transparent Medicare Drug Price Negotiation

Share This Article